Skip to main content
. 2020 Sep 1;74(9):698–704. doi: 10.1136/jech-2020-213885

Table 3.

Differences† in mean biomarker levels in KYH vs Tromsø 7 adjusted for CVD risk factors

N Model 1 (adjusted for age) Model 2 (adjusted for age, smoking, BMI, WHR, SBP, DBP, diabetes, education) Model 3 (adjusted for age, smoking, BMI, WHR, SBP, DBP, diabetes, education, lipid-lowering drugs)
Men
Total cholesterol 9669 −0.22 (−0.29, −0.1) −0.31 (−0.39, −0.19) −0.30 (−0.38, −0.17)
HDL 9669 −0.05 (−0.07, −0.02) −0.05 (−0.07, −0.02) −0.05 (−0.07, −0.02)
LDL 9679 −0.26 (−0.34, −0.22) −0.32 (−0.41, −0.28) −0.31 (−0.39, −0.27)
Triglycerides‡§ 9454 0.03 (0.00, 0.07) 0.02 (−0.01, 0.06) 0.02 (−0.01, 0.06)
hsCRP‡ 9669 0.29 (0.23, 0.35) 0.16 (0.10, 0.22) 0.17 (0.11, 0.22)
NT-proBNP‡ 2192 0.44 (0.36, 0.53) 0.37 (0.27, 0.47) 0.37 (0.27, 0.46)
hs-cTnT‡ 2197 0.36 (0.31, 0.40) 0.37 (0.32, 0.42) 0.37 (0.32, 0.42)
Women
Total cholesterol 11 189 −0.07 (−0.15, 0.04) −0.13 (−0.21, −0.01) −0.09 (−0.17, 0.03)
HDL 11 189 −0.13 (−0.16, −0.11) −0.02 (−0.04, 0.01) −0.02 (−0.04, 0.01)
LDL 11 189 −0.03 (−0.10, 0.01) −0.13 (−0.21, −0.09) −0.09 (−0.17, −0.05)
Triglycerides‡ 10 859 0.10 (0.07, 0.12) 0.03 (0.00, 0.06) 0.03 (0.00, 0.06)
hsCRP‡ 11 189 0.31 (0.26, 0.35) 0.04 (−0.01, 0.10) 0.05 (0, 0.11)
NT-proBNP‡ 2876 0.27 (0.21, 0.33) 0.33 (0.25, 0.39) 0.32 (0.24, 0.38)
hs-cTnT‡ 2880 0.52 (0.48, 0.55) 0.49 (0.45, 0.53) 0.49 (0.45, 0.53)

†Values in KYH minus those in Tromsø 7 and 95% CIs, all models based on cases without missing data on adjustment variables.

‡Analysis is based on ln-transformed values.

§The models for triglycerides were additionally adjusted for fasting time because of differences in mean fasting time in the two studies. Fasting time was recorded from participants' self-report.

BMI, body mass index; CVD, cardiovascular disease; DBP, diastolic blood pressure; HDL, high-density lipoprotein, hsCRP, high-sensitivity C-reactive protein; hs-cTnT, high-sensitivity cardiac troponin T; KYH, Know Your Heart; LDL, low-density lipoprotein; NT-proBNP, N-terminal pro-b-type natriuretic peptide; systolic blood pressure; WHR, waist-to-hip ratio.